Express News | Mira Pharmaceuticals Announces Approval and Initiation of Phase 1 Clinical Trial for Ketamir-2 in Neuropathic Pain

ReutersMar 4 08:08 ET

Tariffs Expected to Bring Pharmaceutical Price Bumps, Shortages -- Market Talk

WSJFeb 10 10:43 ET

Here's Why We're Not Too Worried About MIRA Pharmaceuticals' (NASDAQ:MIRA) Cash Burn Situation

Yahoo FinanceJan 5 08:16 ET

MIRA Pharmaceuticals Submits IND for Ketamir-2 to FDA, Marking a Significant Milestone in the Company's Pipeline Development

AccesswireDec 19, 2024 09:00 ET

Express News | Mira Pharmaceuticals Inc - Submits Ind Application to FDA for Ketamir-2

ReutersDec 19, 2024 08:34 ET

Express News | Mira Pharmaceuticals Inc: Submission of Investigational New Drug (Ind) Application by End of 2024

ReutersDec 10, 2024 08:47 ET

Express News | EXCLUSIVE: Mira Pharmaceuticals Tells Benzinga 'Advancing Ketamir-2 Into Clinical Trials as Quickly as Possible Reflects Our Strategic Focus on Generating Proof-of-concept Data That Positions MIRA for a Potential M&A Transaction or Strategic Partnership'

BenzingaDec 10, 2024 08:15 ET

EXCLUSIVE: MIRA Pharmaceuticals Validates Ketamir-2's Safety Profile, Paving Way For Human Trials In Neuropathic Pain

BenzingaDec 10, 2024 08:15 ET

Express News | EXCLUSIVE: Mira Pharmaceuticals Tells Benzinga 'Strong Safety Profile Validated Across Studies, Setting the Stage for Clinical Trials in Neuropathic Pain'

BenzingaDec 10, 2024 08:15 ET

Express News | EXCLUSIVE: Mira Pharmaceuticals Tells Benzinga Co. Validates Ketamir-2's Safety Profile With No Adverse Finding, Says Paving The Way For IND Submission By Year-End

BenzingaDec 10, 2024 08:15 ET

MIRA Pharmaceuticals Appoints New Board Member and Chairman

TipRanksNov 21, 2024 16:48 ET

Express News | Mira Pharmaceuticals Announced The Selection Of The Centre For Human Drug Research In Leiden, The Netherlands, As The Site For Its Phase I/IIa Clinical Trial Of Ketamir-2, A Novel Oral Ketamine Analog

BenzingaNov 20, 2024 07:46 ET

MIRA Reveals Innovative Phase I/IIa Protocol Design and Selection of Clinical Trial Site

AccesswireNov 20, 2024 07:44 ET

US Manufacturing Index Rises To 43, Highest Since 2020

Business TodayNov 16, 2024 02:13 ET

MIRA Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

SECNov 12, 2024 16:50 ET · Announcements

Trending Stocks Today | Pixie Dust Technologies Shoots up 186.56% Post-Market

Moomoo NewsOct 25, 2024 18:00 ET

12 Health Care Stocks Moving In Friday's After-Market Session

BenzingaOct 25, 2024 16:31 ET

Express News | Watching MIRA Pharmaceuticals; Zacks Small-Cap Research Gives Stock $17.75 Price Valuation, Says Co Is Creating A THC Analog That Has The Same Benefits As THC Without The Negative Side Effects

BenzingaOct 21, 2024 10:09 ET

MIRA Pharmaceuticals Announces Ketamir-2 Outperforms Current FDA-Approved Neuropathic Pain Treatments, Gabapentin and Pregabalin, in Preclinical Study

AccesswireOct 21, 2024 07:30 ET

Express News | Mira Pharmaceuticals - Remains on Track to Submit Ind Application by End of 2024, With Phase I Clinical Trials Expected to Begin in Q1 2025

ReutersOct 21, 2024 07:03 ET